Physician profile
Janos Barrera
NPI 1477907665
$3,171.18
in general payments reported to CMS, 2019-2025
11 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $1,621 · 2023: $113 · 2024: $950 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $956.71 | 2022 | |
| Acumed LLC | $681.25 | 2024-2025 | Acumed, Innate Implant, Inframe Implant |
| Allergan, INC. | $664.34 | 2022 | |
| Depuy Synthes Sales INC. | $288.18 | 2024-2025 | Na, Hammerlock, Lcp |
| Davol INC. | $145.68 | 2021 | |
| Skeletal Dynamics INC | $120.96 | 2024 | Implate, Align, Ijs |
| Abbvie INC. | $113.38 | 2023 | Natrelle Saline-Filled Breast Implants |
| Medical Device Business Services, INC. | $105.45 | 2024-2025 | Va-Lcp |
| Integra Lifesciences Corporation | $49.41 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $26.18 | 2025 | Novosorb Btm |
| Opko Pharmaceuticals, LLC | $19.64 | 2024 | Rayaldee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janos Barrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.